Skip to main content
SpringerLink
Log in

Efficacy of optimal medical therapy and cardiac resynchronization therapy upgrade in patients with pacemaker-induced cardiomyopathy

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

The aim of our study was to assess the prevalence of pacemaker-induced cardiomyopathy (PMiCMP) and its response to biventricular stimulation and optimal medical therapy.

Methods

To identify patients with PMiCMP, we screened all patients that presented for pacemaker interrogation in our outpatient clinic in 2012 and 2013 (n = 615). Left ventricular (LV) function was assessed by transthoracic echocardiography. PMiCMP was defined as deterioration of left ventricular ejection fraction (LVEF) <45 % unexplained by other cardiac disease under a right ventricular (RV) pacing percentage ≥90 %. If symptoms and LV dysfunction persisted under heart failure medication, patients were offered to receive an upgrade to biventricular stimulation (cardiac resynchronization therapy, CRT). CRT response was defined as a decrease of the LV end-systolic volume (LVESV) of ≥15 %.

Results

Thirty-seven patients were found to have a PMiCMP. The prevalence of PMiCMP in our total cohort was 6.0 %. In 20 PMiCMP patients, an upgrade to a CRT device was performed after a minimum of 3 months of optimal medical therapy. The remaining PMiCMP patients either refused an upgrade or were in good functional status. The LVEF before CRT upgrade was 33.3 ± 5.2 % and improved to 47.6 ± 9.3 % (P < 0.001) within 6 months. Positive response to CRT was observed in 17 patients (85 %). In the group without device upgrade, LVEF was 40.5 ± 5 % and did not change during the follow-up period of 1 year.

Conclusions

Optimal medical therapy lacks efficacy in PMiCMP patients. The response rate to CRT was significantly higher in PMiCMP patients compared to average CRT patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig 2
Fig. 3
Fig 4

Similar content being viewed by others

References

  1. Delgado, V., Tops, L. F., Trines, S. A., Zeppenfeld, K., Marsan, N. A., Bertini, M., Holman, E. R., Schalij, M. J., & Bax, J. J. (2009). Acute effects of right ventricular apical pacing on left ventricular synchrony and mechanics. Circulation. Arrhythmia and Electrophysiology, 2(2), 135–145.

    Article  PubMed  Google Scholar 

  2. Nahlawi, M., Waligora, M., Spies, S. M., Bonow, R. O., Kadish, A. H., & Goldberger, J. J. (2004). Left ventricular function during and after right ventricular pacing. Journal of the American College of Cardiology, 44(9), 1883–1888.

    Article  PubMed  Google Scholar 

  3. Nielsen, J. C., Andersen, H. R., Thomsen, P. E., Thuesen, L., Mortensen, P. T., Vesterlund, T., & Pedersen, A. K. (1998). Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation, 97(10), 987–995.

    Article  CAS  PubMed  Google Scholar 

  4. Sweeney, M. O., Hellkamp, A. S., Ellenbogen, K. A., Greenspon, A. J., Freedman, R. A., Lee, K. L., Lamas, G. A., & Investigators, M. O. S. T. (2003). Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation, 107(23), 2932–2937.

    Article  PubMed  Google Scholar 

  5. Chan, J. Y., Fang, F., Zhang, Q., Fung, J. W., Razali, O., Azlan, H., Lam, K. H., Chan, H. C., & Yu, C. M. (2011). Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. European Heart Journal, 32(20), 2533–2540.

    Article  PubMed  Google Scholar 

  6. Funck, R. C., Blanc, J. J., Mueller, H. H., Schade-Brittinger, C., Bailleul, C., Maisch, B., & BioPace Study G. (2006). Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the ‘Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)’ study. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 8(8), 629–635.

    Article  Google Scholar 

  7. Kanzaki, H., Bazaz, R., Schwartzman, D., Dohi, K., Sade, L. E., & Gorcsan, J., 3rd. (2004). A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. Journal of the American College of Cardiology, 44(8), 1619–1625.

    Article  PubMed  Google Scholar 

  8. European Society of C, European Heart Rhythm A, Brignole, M., Auricchio, A., Baron-Esquivias, G., Bordachar, P., Boriani, G., Breithardt, O. A., Cleland, J., Deharo, J. C., Delgado, V., Elliott, P. M., Gorenek, B., Israel, C. W., Leclercq, C., Linde, C., Mont, L., Padeletti, L., Sutton, R., & Vardas, P. E. (2013). 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 15(8), 1070–1118.

    Article  Google Scholar 

  9. Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A., 3rd, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O., Tracy, C. M., Darbar, D., Dunbar, S. B., Ferguson, T. B., Jr., Karasik, P. E., Link, M. S., Marine, J. E., Shanker, A. J., Stevenson, L. W., Stevenson, W. G., Varosy, P. D., American College of Cardiology F, & American Heart Association Task Force on Practice G, Heart Rhythm S. (2013). 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 61(3), e6–75.

    Article  PubMed  Google Scholar 

  10. Zhang, X. H., Chen, H., Siu, C. W., Yiu, K. H., Chan, W. S., Lee, K. L., Chan, H. W., Lee, S. W., Fu, G. S., Lau, C. P., & Tse, H. F. (2008). New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function. Journal of Cardiovascular Electrophysiology, 19(2), 136–141.

    Article  PubMed  Google Scholar 

  11. Dreger, H., Maethner, K., Bondke, H., Baumann, G., & Melzer, C. (2012). Pacing-induced cardiomyopathy in patients with right ventricular stimulation for >15 years. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 14(2), 238–242.

    Article  Google Scholar 

  12. Toff, W. D., Camm, A. J., Skehan, J. D., United Kingdom P, & Cardiovascular Events Trial I. (2005). Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. New England Journal of Medicine, 353(2), 145–155.

    Article  CAS  PubMed  Google Scholar 

  13. Leclercq, C., Cazeau, S., Lellouche, D., Fossati, F., Anselme, F., Davy, J. M., Sadoul, N., Klug, D., Mollo, L., & Daubert, J. C. (2007). Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: the RD-CHF Study. Pacing and Clinical Electrophysiology, 30(Suppl 1), S23–30.

    PubMed  Google Scholar 

  14. Nazeri, A., Massumi, A., Rasekh, A., Saeed, M., Frank, C., & Razavi, M. (2010). Cardiac resynchronization therapy in patients with right ventricular pacing-induced cardiomyopathy. Pacing and Clinical Electrophysiology, 33(1), 37–40.

    Article  PubMed  Google Scholar 

  15. Kirkfeldt, R. E., Johansen, J. B., Nohr, E. A., Jorgensen, O. D., & Nielsen, J. C. (2014). Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. European Heart Journal, 35(18), 1186–1194.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Yu, C. M., Chan, J. Y., Zhang, Q., Omar, R., Yip, G. W., Hussin, A., Fang, F., Lam, K. H., Chan, H. C., & Fung, J. W. (2009). Biventricular pacing in patients with bradycardia and normal ejection fraction. New England Journal of Medicine, 361(22), 2123–2134.

    Article  PubMed  Google Scholar 

  17. van Geldorp, I. E., Vernooy, K., Delhaas, T., Prins, M. H., Crijns, H. J., Prinzen, F. W., & Dijkman, B. (2010). Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 12(2), 223–229.

    Article  Google Scholar 

  18. Khurshid, S., Epstein, A. E., Verdino, R. J., Lin, D., Goldberg, L. R., Marchlinski, F. E., & Frankel, D. S. (2014). Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm.

  19. Park, H. E., Kim, J. H., Kim, H. K., Lee, S. P., Choi, E. K., Kim, Y. J., Oh, S., Cho, G. Y., & Sohn, D. W. (2012). Ventricular dyssynchrony of idiopathic versus pacing-induced left bundle branch block and its prognostic effect in patients with preserved left ventricular systolic function. The American Journal of Cardiology, 109(4), 556–562.

    Article  PubMed  Google Scholar 

  20. Kang, S. J., Song, J. K., Yang, H. S., Song, J. M., Kang, D. H., Rhee, K. S., Nam, G. B., Choi, K. J., Kim, J. J., & Kim, Y. H. (2004). Systolic and diastolic regional myocardial motion of pacing-induced versus idiopathic left bundle branch block with and without left ventricular dysfunction. The American Journal of Cardiology, 93(10), 1243–1246.

    Article  PubMed  Google Scholar 

  21. Sweeney, M. O., & Hellkamp, A. S. (2006). Heart failure during cardiac pacing. Circulation, 113(17), 2082–2088.

    Article  PubMed  Google Scholar 

  22. Cano, O., Osca, J., Sancho-Tello, M. J., Sanchez, J. M., Ortiz, V., Castro, J. E., Salvador, A., & Olague, J. (2010). Comparison of effectiveness of right ventricular septal pacing versus right ventricular apical pacing. The American Journal of Cardiology, 105(10), 1426–1432.

    Article  PubMed  Google Scholar 

  23. Zanon, F., Bacchiega, E., Rampin, L., Aggio, S., Baracca, E., Pastore, G., Marotta, T., Corbucci, G., Roncon, L., Rubello, D., & Prinzen, F. W. (2008). Direct his bundle pacing preserves coronary perfusion compared with right ventricular apical pacing: a prospective, cross-over mid-term study. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 10(5), 580–587.

    Article  Google Scholar 

  24. Deshmukh, P., Casavant, D. A., Romanyshyn, M., & Anderson, K. (2000). Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation, 101(8), 869–877.

    Article  CAS  PubMed  Google Scholar 

  25. Flather, M. D., Yusuf, S., Kober, L., Pfeffer, M., Hall, A., Murray, G., Torp-Pedersen, C., Ball, S., Pogue, J., Moye, L., & Braunwald, E. (2000). Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet, 355(9215), 1575–1581.

    Article  CAS  PubMed  Google Scholar 

  26. The SOLVD Investigators. (1992). Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine, 327(10), 685–691.

    Article  Google Scholar 

  27. The MERIT-HF Study Group. (1999). Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet, 353(9169), 2001–2007.

  28. Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine, 341(10), 709–717.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Medizinische Klinik für Kardiologie und Angiologie, Campus Mitte Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany

      Marius Schwerg, Henryk Dreger, Wolfram C. Poller, Benjamin Dust & Christoph Melzer

    Authors
    1. Marius Schwerg
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Henryk Dreger
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Wolfram C. Poller
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Benjamin Dust
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Christoph Melzer
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Marius Schwerg.

    Ethics declarations

    Ethics approval and consent to participate

    The study conforms to the Declaration of Helsinki. The study is approved by the ethics committee of the Charite Universitätsmedizin Berlin. All patients provided written informed consent.

    Additional information

    Marius Schwerg and Henryk Dreger contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Schwerg, M., Dreger, H., Poller, W.C. et al. Efficacy of optimal medical therapy and cardiac resynchronization therapy upgrade in patients with pacemaker-induced cardiomyopathy. J Interv Card Electrophysiol 44, 289–296 (2015). https://doi.org/10.1007/s10840-015-0059-4

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10840-015-0059-4

    Keywords

    Search

    Navigation